<?xml version="1.0" encoding="UTF-8"?><ns2:project xmlns:ns1="http://gtr.rcuk.ac.uk/gtr/api" xmlns:ns2="http://gtr.rcuk.ac.uk/gtr/api/project" xmlns:ns3="http://gtr.rcuk.ac.uk/gtr/api/fund" xmlns:ns4="http://gtr.rcuk.ac.uk/gtr/api/person" xmlns:ns5="http://gtr.rcuk.ac.uk/gtr/api/project/outcome" xmlns:ns6="http://gtr.rcuk.ac.uk/gtr/api/organisation" ns1:created="2026-06-22T07:57:45Z" ns1:href="http://gtr.ukri.org/gtr/api/projects/FFFEE869-7124-4176-89D3-3421AAF75CAE" ns1:id="FFFEE869-7124-4176-89D3-3421AAF75CAE"><ns1:links><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/persons/8D7EB6B6-C06F-4C53-995F-4CC3CEC73179" ns1:rel="PM_PER"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/2E15410B-8578-4BAF-82A7-E785B36F661E" ns1:rel="LEAD_ORG"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/2E15410B-8578-4BAF-82A7-E785B36F661E" ns1:rel="PARTICIPANT_ORG"/><ns1:link ns1:end="2022-03-30T23:00:00Z" ns1:href="http://gtr.ukri.org/gtr/api/funds/558DFBA9-4A50-4D48-9840-80ED4E523600" ns1:rel="FUND" ns1:start="2019-02-01T00:00:00Z"/></ns1:links><ns2:identifiers><ns2:identifier ns2:type="RCUK">104902</ns2:identifier></ns2:identifiers><ns2:title>Using adeno-associated virus gene therapy to treat rare kidney disease</ns2:title><ns2:status>Closed</ns2:status><ns2:grantCategory>Collaborative R&amp;D</ns2:grantCategory><ns2:leadFunder>Innovate UK</ns2:leadFunder><ns2:abstractText>Freeline is requesting a change of scope to project number 104902 – “Using AAV gene therapy to treat rare kidney disease” that would redistribute funds to enable critical safety risk mitigation experiments to be performed within the timelines of the grant.</ns2:abstractText></ns2:project>